Mela Sciences’ U.S. rollout of its MelaFind melanoma detection device in the first quarter of 2012 will initially be limited to the Northeast, the company says.
The firm, which announced the long-awaited PMA approval of the non-invasive, multi-spectral dermascope on Nov
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?